Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D00FPJ
|
||||
| Former ID |
DNC005330
|
||||
| Drug Name |
3,4,6-Trihydroxy-2-(4-hydroxy-phenyl)-inden-1-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [1] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C15H10O5
|
||||
| Canonical SMILES |
C1=CC(=CC=C1C2=C(C3=CC(=CC(=C3C2=O)O)O)O)O
|
||||
| InChI |
1S/C15H10O5/c16-8-3-1-7(2-4-8)12-14(19)10-5-9(17)6-11(18)13(10)15(12)20/h1-6,16-19H
|
||||
| InChIKey |
LQBURCXFHFUJJI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor beta | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Estrogen signaling pathway | ||||
| Prolactin signaling pathway | |||||
| Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
| Validated nuclear estrogen receptor beta network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Reactome | Nuclear Receptor transcription pathway | ||||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Ovarian Infertility Genes | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Nuclear Receptors | |||||
| References | |||||
| REF 1 | Bioorg Med Chem Lett. 2005 Jun 15;15(12):3137-42.Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.